Hamilton Lane Advisors’s Intersect ENT, Inc XENT Stock Holding History

Hamilton Lane Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,560	Closed	-$372K	–	62
2019 Q1	$372K	Sell	11,560 -10,000	-46%	-$309K	0.2%	45
2018 Q4	$608K	Hold	21,560	–	–	0.53%	34
2018 Q3	$1K	Hold	21,560	–	–	0.41%	40
2018 Q2	$1K	Hold	21,560	–	–	0.91%	33
2018 Q1	$1K	Hold	21,560	–	–	0.79%	34
2017 Q4	$699K	Sell	21,560 -10,000	-32%	-$300K	0.36%	41
2017 Q3	$983K	Sell	31,560 -5,000	-14%	-$148K	0.68%	30
2017 Q2	$1.02M	Buy	+36,560	New	+$828K	0.56%	32
2015 Q4	–	Sell	-38,086	Closed	-$891K	–	63
2015 Q3	$891K	Sell	38,086 -8,114	-18%	-$224K	0.44%	36
2015 Q2	$1.32M	Buy	46,200 +18,870	+69%	+$495K	0.5%	36
2015 Q1	$706K	Buy	+27,330	New	+$625K	0.32%	34

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Hamilton Lane Advisors's XENT Position: Q2 2019 in Review

Hamilton Lane Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 11,560 shares — an estimated $372K sold.

Hamilton Lane Advisors first reported a position in XENT in Q1 2015 and held it in 11 quarters. The position peaked at $1.32M in Q2 2015. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

Hamilton Lane Advisors reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
Hamilton Lane Advisors sold 11,560 Intersect ENT, Inc shares in Q2 2019, an estimated $372K.
Hamilton Lane Advisors first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 11 quarters.
Hamilton Lane Advisors's Intersect ENT, Inc position peaked at $1.32M in Q2 2015.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Hamilton Lane Advisors's 13F filing for Q2 2019, filed 29 Jul 2019.